We also report that DYRK1A is required to suppress the proapoptotic molecule BIM and that DYRK1A inhibition consequently renders KMT2A-R ALL cells sensitive to BCL2 inhibition. Here, BCL2L11 is linked to acute lymphoblastic leukemia.